KELLY ANDREWS: Open Payments
NPI 1679149983 · MACCLENNY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 14 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $185 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $139 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Corcept Therapeutics | 3 | $61 |
| CORDIS US CORP. | 1 | $23 |
| Teleflex LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Veozah, Korlym, MYNX CONTROL, BREZTRI, TRAPLINER, FARXIGA, MOUNJARO, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
